These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1423242)

  • 1. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
    Chen G; Zeller WJ
    Cancer Lett; 1992 Oct; 67(1):27-33. PubMed ID: 1423242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.
    Chen G; Zeller WJ
    J Cancer Res Clin Oncol; 1990; 116(5):443-7. PubMed ID: 2121738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells.
    Chen G; Zeller WJ
    Anticancer Res; 1994; 14(4A):1461-7. PubMed ID: 7979172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of acquired-resistance to Cisplatin in a rat ovarian tumor-cell line.
    Chen G; Hutter K; Zeller W
    Int J Oncol; 1992 Jul; 1(2):135-40. PubMed ID: 21584522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.
    Chen G; Zeller WJ
    Cancer Chemother Pharmacol; 1993; 33(2):157-62. PubMed ID: 8261576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.
    Frühauf S; Zeller WJ
    Cancer Res; 1991 Jun; 51(11):2943-8. PubMed ID: 2032232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G; Zeller WJ
    Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.
    Bernges F; Zeller WJ
    J Cancer Res Clin Oncol; 1996; 122(11):665-70. PubMed ID: 8898976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide and nicotinamide.
    Chen G; Pan QC
    Cancer Chemother Pharmacol; 1988; 22(4):303-7. PubMed ID: 2971467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.
    Bürkle A; Chen G; Küpper JH; Grube K; Zeller WJ
    Carcinogenesis; 1993 Apr; 14(4):559-61. PubMed ID: 8472314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.
    Chen G; Zeller WJ
    Cancer Chemother Pharmacol; 1990; 26(1):37-41. PubMed ID: 2322989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.
    Frühauf S; Zeller WJ
    Cancer Chemother Pharmacol; 1991; 27(4):301-7. PubMed ID: 1998986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase, is a stimulator, not an inhibitor, of DNA repair.
    Cleaver JE; Morgan WF
    Exp Cell Res; 1987 Oct; 172(2):258-64. PubMed ID: 3115799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y; Chen H; Yang Q
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of thaliblastine (NSC-68075) in experimental ovarian tumor cell lines sensitive and resistant to cisplatin.
    Chen G; Todorov DK; Zeller WJ
    Cancer Lett; 1992 Feb; 62(2):173-7. PubMed ID: 1531781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells.
    Katz EJ; Andrews PA; Howell SB
    Cancer Commun; 1990; 2(4):159-64. PubMed ID: 2114928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3-aminobenzamide on the rejoining of DNA-strand breaks in mammalian cells exposed to methyl methanesulphonate; role of poly(ADP-ribose) polymerase.
    Ahnström G; Ljungman M
    Mutat Res; 1988 Jul; 194(1):17-22. PubMed ID: 3133560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibitors of poly(ADP-ribose)polymerase on the radiation response of HeLa S3 cells.
    Burgman P; Konings AW
    Radiat Res; 1989 Aug; 119(2):380-6. PubMed ID: 2502817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.